Mairs & Power Inc’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$728K Sell
8,050
-3,050
-27% -$280K 0.01% 167
2025
Q4
$998K Sell
11,100
-2,855
-20% -$271K 0.01% 151
2025
Q3
$1.37M Sell
13,955
-325
-2% -$32.2K 0.01% 131
2025
Q2
$1.3M Sell
14,280
-170
-1% -$16.4K 0.01% 129
2025
Q1
$1.64M Sell
14,450
-250
-2% -$26.7K 0.02% 119
2024
Q4
$1.55M Sell
14,700
-1,000
-6% -$107K 0.02% 120
2024
Q3
$1.69M Sell
15,700
-600
-4% -$65.5K 0.02% 118
2024
Q2
$1.77M Sell
16,300
-200
-1% -$23.6K 0.02% 114
2024
Q1
$2.18M Sell
16,500
-1,795
-10% -$224K 0.02% 112
2023
Q4
$2.23M Sell
18,295
-2,490
-12% -$278K 0.02% 116
2023
Q3
$2.33M Sell
20,785
-1,870
-8% -$237K 0.03% 111
2023
Q2
$3.3M Sell
22,655
-3,826
-14% -$520K 0.04% 104
2023
Q1
$3.42M Sell
26,481
-3,405
-11% -$428K 0.04% 100
2022
Q4
$3.81M Sell
29,886
-1,214
-4% -$141K 0.05% 101
2022
Q3
$3.25M Sell
31,100
-3,726
-11% -$409K 0.04% 101
2022
Q2
$3.66M Sell
34,826
-49,583
-59% -$5.88M 0.04% 101
2022
Q1
$10.8M Sell
84,409
-73,772
-47% -$8.89M 0.11% 74
2021
Q4
$19.5M Sell
158,181
-60,021
-28% -$7.86M 0.18% 61
2021
Q3
$31M Sell
218,202
-42,445
-16% -$6.24M 0.31% 56
2021
Q2
$40.7M Sell
260,647
-104,623
-29% -$16.9M 0.4% 50
2021
Q1
$56.8M Sell
365,270
-200,656
-35% -$31.1M 0.6% 41
2020
Q4
$84.7M Sell
565,926
-301,348
-35% -$42.6M 0.94% 36
2020
Q3
$115M Sell
867,274
-140,578
-14% -$18.4M 1.43% 29
2020
Q2
$117M Sell
1,007,852
-8,893
-0.9% -$1.02M 1.53% 26
2020
Q1
$99.8M Buy
1,016,745
+40,655
+4% +$5.33M 1.46% 27
2019
Q4
$142M Sell
976,090
-26,287
-3% -$3.63M 1.61% 24
2019
Q3
$134M Sell
1,002,377
-56,228
-5% -$7.26M 1.61% 24
2019
Q2
$121M Sell
1,058,605
-1,756
-0.2% -$206K 1.45% 27
2019
Q1
$131M Buy
1,060,361
+3,041
+0.3% +$346K 1.6% 23
2018
Q4
$106M Sell
1,057,320
-15,041
-1% -$1.69M 1.44% 27
2018
Q3
$137M Sell
1,072,361
-53,571
-5% -$6.37M 1.59% 24
2018
Q2
$122M Sell
1,125,932
-14,826
-1% -$1.61M 1.51% 28
2018
Q1
$121M Buy
1,140,758
+4,705
+0.4% +$546K 1.49% 28
2017
Q4
$133M Buy
1,136,053
+6,672
+0.6% +$754K 1.54% 27
2017
Q3
$128M Buy
1,129,381
+18,601
+2% +$2.15M 1.54% 28
2017
Q2
$138M Buy
1,110,780
+19,021
+2% +$2.26M 1.67% 24
2017
Q1
$129M Buy
1,091,759
+83,351
+8% +$9.45M 1.59% 27
2016
Q4
$101M Buy
1,008,408
+134,842
+15% +$14.5M 1.3% 32
2016
Q3
$110M Sell
873,566
-1,267
-0.1% -$157K 1.45% 30
2016
Q2
$102M Buy
874,833
+6,130
+0.7% +$694K 1.38% 30
2016
Q1
$89.9M Buy
868,703
+100,449
+13% +$9.72M 1.28% 31
2015
Q4
$76.5M Buy
768,254
+223,245
+41% +$21.8M 1.15% 35
2015
Q3
$49.7M Buy
545,009
+2,729
+0.5% +$274K 0.78% 44
2015
Q2
$57.5M Sell
542,280
-4,604
-0.8% -$509K 0.81% 42
2015
Q1
$62.4M Sell
546,884
-28,421
-5% -$3.24M 0.86% 41
2014
Q4
$63.4M Sell
575,305
-74,312
-11% -$7.83M 0.88% 41
2014
Q3
$63.4M Sell
649,617
-6,823
-1% -$671K 0.93% 38
2014
Q2
$66.2M Sell
656,440
-24,399
-4% -$2.38M 0.94% 38
2014
Q1
$62.5M Sell
680,839
-2,138
-0.3% -$197K 0.93% 38
2013
Q4
$61.8M Sell
682,977
-6,698
-1% -$580K 0.95% 38
2013
Q3
$55M Sell
689,675
-26,713
-4% -$2.1M 0.95% 36
2013
Q2
$52.1M Buy
+716,388
New +$53.6M 1% 35

Other funds holding ZBH

Mairs & Power Inc's ZBH Position: Q1 2026 in Review

Mairs & Power Inc reduced its Zimmer Biomet (ZBH) stake by 27% in Q1 2026, selling an estimated $280K and leaving 8,050 shares worth $728K. The position accounts for 0.01% of the portfolio, ranked #167.

Mairs & Power Inc first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $142M in Q4 2019. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Mairs & Power Inc held 8,050 shares of Zimmer Biomet worth $728K as of Q1 2026.
  • Mairs & Power Inc sold 3,050 Zimmer Biomet shares in Q1 2026, an estimated $280K.
  • Zimmer Biomet made up 0.01% of Mairs & Power Inc's portfolio in Q1 2026, its #167 holding.
  • Mairs & Power Inc first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Mairs & Power Inc's Zimmer Biomet position peaked at $142M in Q4 2019.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Mairs & Power Inc's 13F filing for Q1 2026, filed 14 May 2026.